Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.72 |
| ▸ | RAB9A | P51151 | 3/20 | 0.72 |
| ▸ | RECQL | P46063 | 2/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.64 |
| ▸ | LMNA | P02545 | 3/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.60 |
| ▸ | MAPT | P10636 | 4/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 3/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | THRA | P10827 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8055173 | 1.00 | NPC1 (0.72) | NPC1RAB9ARECQLALDH1A1LMNA | |
| SCHEMBL30517741 | 1.00 | NPC1 (0.72) | NPC1RAB9ARECQLALDH1A1LMNA | |
| SCHEMBL50769 | 1.00 | NPC1 (0.72) | NPC1RAB9ARECQLALDH1A1LMNA | |
| SCHEMBL29794119 | 1.00 | NPC1 (0.72) | NPC1RAB9ARECQLALDH1A1LMNA | |
| SCHEMBL2304857 | 1.00 | NPC1 (0.72) | NPC1RAB9ARECQLALDH1A1LMNA | |
| SCHEMBL18012379 | 1.00 | NPC1 (0.72) | NPC1RAB9ARECQLALDH1A1LMNA | |
| SCHEMBL8581954 | 1.00 | NPC1 (0.72) | NPC1RAB9ARECQLALDH1A1LMNA | |
| SCHEMBL31734218 | 1.00 | NPC1 (0.72) | NPC1RAB9ARECQLALDH1A1LMNA | |
| SCHEMBL29361974 | 1.00 | NPC1 (0.72) | NPC1RAB9ARECQLALDH1A1LMNA | |
| SCHEMBL3462898 | 1.00 | NPC1 (0.72) | NPC1RAB9ARECQLALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1455919-B1 | IODINE EXTRACTION METHOD | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2011-02-09 | — | — | EP | claimed |
| US-20100224030-A1 | INDIUM RECOVERY BY SUPPORTED LIQUID MEMBRANE WITH STRIP DISPERSION | CHUNG YUAN CHRISTIAN UNIVERSITY (TW) | 2010-09-09 | — | — | US | claimed |
| US-6433163-B1 | EXTRACTION, SEPARATION | COMMODORE SEPARATION TECHNOLIGIES, INC. | 2002-08-13 | — | — | US | claimed |
| US-6350419-B1 | SUPPORTED LIQUID MEMBRANE/ STRIP DISPERSION FOR REMOVAL OF METALS | COMMODORE SEPARATION TECHNOLOGIES INC. | 2002-02-26 | — | — | US | claimed |
| US-6328782-B1 | TREATING FEED SOLUTION CONTAINING RADIONUCLIDES OR METALS BY PASSING FEED SOLUTION ON ONE SIDE OF SUPPORTED LIQUID MEMBRANE EMBEDDED IN MICROPOROUS SUPPORT AND REMOVING RADIONUCLIDES BY USE OF STRIP DISPERSION ON OTHER SIDE OF MEMBRANE; SEPARATION | COMMODORE SEPARATION TECHNOLOGIES, INC. | 2001-12-11 | — | — | US | claimed |
| US-20010029810-A1 | Alkyl phenylphosphonic acid extractants and processes for their manufacture | HO W S WINSTON (US) | 2001-10-18 | — | — | US | claimed |
| WO-2001056933-A2 | COMBINED SUPPORTED LIQUID MEMBRANE/STRIP DISPERSION PROCESSES AND EXTRACTANTS | COMMODORE SEPARATION TECHNOLOGIES, INC. (US) | 2001-08-09 | — | — | WO | claimed |
| US-6171563-B1 | Supported liquid membrane process for chromium removal and recovery | COMMODORE SEPARATION TECHNOLOGIES, INC. | 2001-01-09 | — | — | US | claimed |
| WO-1998010852-A1 | SUPPORTED LIQUID MEMBRANE SEPARATION | COMMODORE SEPARATION TECHNOLOGIES, INC. (US) | 1998-03-19 | — | — | WO | claimed |
| US-20250034139-A1 | AMINE COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY | PHARMA CINQ, LLC | 2025-01-30 | — | — | US | disclosed |
| US-12139483-B2 | Imidazoquinolyl compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity | PHARMA CINQ, LLC (US) | 2024-11-12 | — | — | US | disclosed |
| US-20210163476-A1 | IMIDAZOQUINOLYL COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY | PHARMA CINQ, LLC | 2021-06-03 | — | — | US | disclosed |
| US-10934284-B2 | Aminoquinazoline compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity | WELLSTAT THERAPEUTICS CORPORATION (US) | 2021-03-02 | — | — | US | disclosed |
| CN-108250142-B | Amine compounds having anti-inflammatory, antifungal, antiparasitic and anticancer activity | 维尔斯达医疗公司 | 2021-01-26 | — | — | CN | disclosed |
| WO-1994024138-A1 | CALIX|4|ARENE CROWN ETHERS, METHOD FOR PREPARING SAME, AND USE THEREOF FOR THE SELECTIVE EXTRACTION OF CAESIUM AND ACTINIDES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1994-10-27 | — | — | WO | disclosed |
| WO-1994012502-A1 | BIS-CROWN CALIX[4]ARENES, METHOD FOR PREPARING SAME AND USE THEREOF FOR SELECTIVELY RECOVERING CESIUM AND ACTINIDES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1994-06-09 | — | — | WO | disclosed |
| US-4975456-A | For inhibiting intestinal absorption of cholesterol and increasing high density lipoprotein | WARNER-LAMBERT COMPANY (US) | 1990-12-04 | — | — | US | disclosed |
| US-4960950-A | Formation of nitrophenyl ethers from polyols and nitroanisoles | THE DOW CHEMICAL COMPANY (US) | 1990-10-02 | — | — | US | disclosed |
| US-4882357-A | ANTICHOLESTEROL AGENT; INCREASES HIGH DENSITY LIPOPROTEINS | WARNER-LAMBERT COMPANY (US) | 1989-11-21 | — | — | US | disclosed |
| EP-0335274-A2 | Formation of nitrophenyl ethers from polyols and nitroanisoles | THE DOW CHEMICAL COMPANY (US) | 1989-10-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210163476-A1 | IMIDAZOQUINOLYL COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY | NOD1, NLRP3, AADAC | NPC1 2710/4885RAB9A 3162/4885RECQL 1531/4885 |
| US-20250034139-A1 | AMINE COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY | AADAC, CASP1, AAAS | NPC1 1958/4885RAB9A 3836/4885RECQL 3510/4885 |
| US-12139483-B2 | Imidazoquinolyl compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity | NOD1, NLRP3, AADAC | NPC1 2710/4885RAB9A 3162/4885RECQL 1531/4885 |
| US-10934284-B2 | Aminoquinazoline compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity | AAAS, AADAC, NFKBIA | NPC1 3086/4885RAB9A 2731/4885RECQL 1210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.